Skip to content

Insider · CIK 0001838995

Debra L Morris

director

Files at PGNY (Progyny, Inc.), REXR (Rexford Industrial Realty, Inc.), BTMD (biote Corp.). First filing -, latest -.

In brief

Debra L Morris files SEC Form 4 as director at PGNY (Progyny, Inc.), and also at REXR (Rexford Industrial Realty, Inc.), BTMD (biote Corp.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.

A track record needs three past buys with six months of prices behind them; Debra L Morris has 0, so none is measured yet.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, 14 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
May 21, 2026PGNY
Progyny, Inc.
AGrant or award
Common Stock
+5,660$0.00$05,660May 26, 2026
May 21, 2026PGNY
Progyny, Inc.
AGrant or award
Stock Option (Right to Buy)derivative
+3,203$12.49$40k3,203May 26, 2026
May 21, 2026PGNY
Progyny, Inc.
AGrant or award
Stock Option (Right to Buy)derivative
+27,119$0.00$027,119May 26, 2026
May 19, 2026REXR
Rexford Industrial Realty, Inc.
AGrant or award
Common Stock, par value $0.01
+4,855$0.00$020,766May 21, 2026
May 12, 2026BTMD
biote Corp.
MOption exercise
Class A Common Stock
+21,407--71,562May 13, 2026
May 12, 2026BTMD
biote Corp.
MOption exercise
Deferred Settlement RSUderivative
-21,407$0.00$00May 13, 2026
May 12, 2026BTMD
biote Corp.
AGrant or award
Deferred Settlement RSUderivative
+39,036$0.00$039,036May 13, 2026
May 12, 2026BTMD
biote Corp.
AGrant or award
Stock Option (Right to Buy)derivative
+130,000$0.00$0130,000May 13, 2026
Jun 3, 2025REXR
Rexford Industrial Realty, Inc.
AGrant or award
Common Stock, par value $0.01
+4,773$0.00$015,911Jun 5, 2025
May 22, 2025PGNY
Progyny, Inc.
AGrant or award
Stock Option (Right to Buy)derivative
+3,591$11.14$40k3,591May 27, 2025
May 13, 2025BTMD
biote Corp.
MOption exercise
Class A Common Stock
+11,045--50,155May 15, 2025
May 13, 2025BTMD
biote Corp.
MOption exercise
Deferred Settlement RSUderivative
-11,045$0.00$00May 15, 2025
May 13, 2025BTMD
biote Corp.
AGrant or award
Deferred Settlement RSUderivative
+21,407$0.00$021,407May 15, 2025
May 13, 2025BTMD
biote Corp.
AGrant or award
Stock Option (Right to Buy)derivative
+104,547$0.00$0104,547May 15, 2025

Questions about Debra L Morris

Answered from the filings on this page, as of the latest one.

Is Debra L Morris buying or selling?

Debra L Morris has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.

How did Debra L Morris's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Debra L Morris has 0.

Where does Debra L Morris file Form 4?

Debra L Morris has filed Form 4 at PGNY (Progyny, Inc.); REXR (Rexford Industrial Realty, Inc.); BTMD (biote Corp.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Debra L Morris: insider trades and track record | InsiderTell